Mylan, the drugmaker feeling the heat over its pricing of the EpiPen, said Monday that it will make an "authorized generic" version of the EpiPen that will cost $300. Before that, to fend off public ...
Agreement with Validus Pharmaceuticals to Market and Distribute Multiple Formulations in the U.S. Healthcare System PRINCETON, N.J., Sept. 2 -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned ...
The drugmaker Eli Lilly will begin selling a cheaper version of its most popular insulin, Humalog, in an effort to head off criticism about the rising costs of prescription drugs, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results